Unraveling the mechanisms of motor neuron degeneration if Spinocerebellar Ataxia, type 1
Unraveling the mechanisms of motor neuron degeneration if Spinocerebellar Ataxia, type 1
批准号:
9757831
负责人:
James P Orengo
金额:
$18.94万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-07-31
关键词:
AddressAffectAgeAlternative SplicingAmyotrophic Lateral SclerosisAstrocytesAtaxiaAutopsyBrain StemBreathingCAG repeatCell DeathCellsCerebellar AtaxiaCerebellar degenerationCervical spinal cord structureCessation of lifeClinicalClustered Regularly Interspaced Short Palindromic RepeatsCre-LoxPDNA cassetteDataDeglutitionDiseaseElectromyographyEnterobacteria phage P1 Cre recombinaseEtiologyEventFaceFunctional disorderGenesGeneticGlutamineGoalsHistologyHumanIndividualIntronsKnock-inKnowledgeLeadLifeLoxP-flanked alleleMapsMeasuresModelingMolecularMorphologyMotorMotor NeuronsMotor PathwaysMovementMusMuscleMuscle FibersMuscle WeaknessMuscular AtrophyNeurodegenerative DisordersNeuromuscular DiseasesNeuronsPathogenesisPathogenicityPathologyPhenotypePlethysmographyPopulationProteinsPulmonary function testsPurkinje CellsRNAResearchRespiratory DiaphragmRespiratory FailureRespiratory physiologyScientistSecondary toStructureSupportive careTimeTongueTrainingType 1 Spinocerebellar AtaxiaWorkcell typeend stage diseasehypoglossal nucleusimprovedinsightmotor neuron degenerationmouse modelnovelpolyglutamineprematureprotein TDP-43protein protein interactionspasticitytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Spinocerebellar ataxia type 1 (SCA1) is a devastating neurodegenerative disease characterized by progressive
ataxia from cerebellar degeneration. Death typically occurs by the third to sixth decade of life. While the
hallmark of SCA1 is loss of motor coordination or ataxia, at the end stage of disease premature death results
from complications secondary to bulbar dysfunction, including swallowing difficulties and breathing dysfunction.
In SCA1, disease is caused by expansion of CAG repeats encoding poly-glutamine (polyQ) in ATAXIN1
(Atxn1). Substantial effort has been invested in determining the molecular mechanism leading to cerebellar
degeneration, specifically Purkinje cell death, from polyQ expanded Atxn1. This is largely due to the fact that
Purkinje cells seem to be the first neurons affected in SCA1 and they are most vulnerable to the pathogenic
sequelae of expanded polyQ Atxn1. However, loss of Purkinje cells does not account for the bulbar dysfunction
phenotype, which ultimately causes premature death. I hypothesize that motor neuron degeneration is
responsible for bulbar dysfunction in SCA1. Further supporting this hypothesis is SCA1 autopsy data showing
marked loss of motor neurons in the brainstem. In 2002 our lab developed a pivotal mouse model for SCA1
recapitulating the major human features of disease with robust face and construct validity. In this model,
designated Atxn1-154Q, 154 CAG repeats were knocked into the endogenous mouse Atxn1 gene locus. Upon
joining the Zoghbi lab, with my clinical expertise in neuromuscular diseases, I made the exciting observation
that these mice display overt signs of motor neuron degeneration. In particular I noted significant muscle
wasting, breathing abnormalities and spasticity by 24 weeks of age. The goals of this proposal are to examine
motor neurons in Atxn1-154Q mice functionally, morphologically and molecularly in order to better understand
what causes their degeneration and to establish these mice as an ideal model to study motor neuron
degeneration in SCA1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Motor Neuron Disease in Spinocerebellar Ataxia, Type1
-
批准号:10733124
-
项目类别:
-
资助金额:$54.21万
-
财政年份:2023
-
负责人:James P Orengo
-
依托单位:
Investigating mechanisms of skeletal muscle degeneration in Myotonic Dystrophy
-
批准号:7485273
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2008
-
负责人:James P Orengo
-
依托单位:
Investigating mechanisms of skeletal muscle degeneration in Myotonic Dystrophy
-
批准号:7574524
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2008
-
负责人:James P Orengo
-
依托单位:
海外基金